Skip to main content

Table 5 miRNA levels in different molecular subtypes of breast cancer

From: MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration

  miR-96 (per million) miR-182 (per million) miR-183 (per million)
HER2-enriched (n = 34) 55.0 ± 46.9* 49308.2 ± 31807.6 24494.0 ± 16871.2*
Basal (n = 105) 42.3 ± 30.6 38971.0 ± 24170.6** 21991.9 ± 16491.6*
Luminal A (n = 406) 40.4 ± 35.5 50347.2 ± 34351.2 17668.1 ± 13604.2
Luminal B (n = 109) 38.0 ± 25.5 43312.6 ± 27928.1 17779.5 ± 13563.3
  1. The expression of each miRNA in miR-183/-96/182 cluster in different molecular subtypes of breast cancer: Patient number is indicated in the first column. Data are presented as mean ± SD. The following markers were used to determine breast cancer subtypes: luminal A (estrogen receptor (ER)+ and/or progesterone receptor (PR)+, human epidermal growth factor (HER)2−), luminal B (ER + and/or PR+, HER2+), basal-like (ER-, PR- , HER2−), HER2-enriched (ER-, PR-, HER2+). Statistical probability (P) was expressed as *P<0.05, **P<0.01.